Qiagen NV Correlations

QGEN Stock

USD 39.65 0.10 0.25%

The current 90-days correlation between Qiagen NV and Neogen is -0.19 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Qiagen NV Correlation With Market

Average diversification

The correlation between Qiagen NV and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Qiagen NV and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.

Moving together with Qiagen Stock

0.66	A	Agilent Technologies	Pair Corr
0.9	ME	23Andme Holding	Pair Corr
0.77	VANI	Vivani Medical Earnings Call This Week	Pair Corr
0.69	DNLI	Denali Therapeutics	Pair Corr
0.71	VCEL	Vericel Corp Ord	Pair Corr
0.74	VCYT	Veracyte	Pair Corr
0.76	VERA	Vera Therapeutics	Pair Corr
0.72	DRTS	Alpha Tau Medical	Pair Corr
0.74	SABSW	SAB Biotherapeutics	Pair Corr
0.76	VINC	Vincerx Pharma	Pair Corr
0.74	VKTX	Viking Therapeutics	Pair Corr
0.8	VRDN	Viridian Therapeutics	Pair Corr
0.72	VRPX	Virpax Pharmaceuticals	Pair Corr
0.79	VTRS	Viatris	Pair Corr
0.87	VTYX	Ventyx Biosciences	Pair Corr

Moving against Qiagen Stock

0.91	VALN	Valneva SE ADR	Pair Corr
0.75	DVAX	Dynavax Technologies	Pair Corr
0.64	EQ	Equillium	Pair Corr
0.63	VIGL	Vigil Neuroscience	Pair Corr
0.55	DMAC	DiaMedica Therapeutics	Pair Corr
0.84	VRNA	Verona Pharma PLC	Pair Corr
0.74	EDSA	Edesa Biotech	Pair Corr
0.72	VRTX	Vertex Pharmaceuticals	Pair Corr
0.71	VTVT	vTv Therapeutics	Pair Corr
0.48	VSTM	Verastem	Pair Corr
0.43	EDIT	Editas Medicine	Pair Corr
0.39	VNDA	Vanda Pharmaceuticals	Pair Corr
0.37	CDTTW	Conduit Pharmaceuticals	Pair Corr
0.32	SRZNW	Surrozen Warrant	Pair Corr

Related Correlations Analysis

	NEOG	OLK	ACRS	SYNH	IQV	MEDP	ICLR	SHC	AKU	GTH
NEOG		0.0	0.81	0.0	0.64	0.48	0.9	0.5	0.0	0.0	NEOG
OLK	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	OLK
ACRS	0.81	0.0		0.0	0.59	0.51	0.73	0.55	0.0	0.0	ACRS
SYNH	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	SYNH
IQV	0.64	0.0	0.59	0.0		0.86	0.61	0.79	0.0	0.0	IQV
MEDP	0.48	0.0	0.51	0.0	0.86		0.53	0.77	0.0	0.0	MEDP
ICLR	0.9	0.0	0.73	0.0	0.61	0.53		0.56	0.0	0.0	ICLR
SHC	0.5	0.0	0.55	0.0	0.79	0.77	0.56		0.0	0.0	SHC
AKU	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	AKU
GTH	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		GTH
	NEOG	OLK	ACRS	SYNH	IQV	MEDP	ICLR	SHC	AKU	GTH

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ICLR	+ 0.9	NEOG
MEDP	+ 0.86	IQV
ACRS	+ 0.81	NEOG
SHC	+ 0.79	IQV
SHC	+ 0.77	MEDP
ICLR	+ 0.73	ACRS

High negative correlations

GTH	- 0.0	AKU
GTH	- 0.0	SHC
AKU	- 0.0	SHC
GTH	- 0.0	ICLR
AKU	- 0.0	ICLR
GTH	- 0.0	MEDP

Risk-Adjusted Indicators

There is a big difference between Qiagen Stock performing well and Qiagen NV Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Qiagen NV's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Potential Upside	Value @Risk	Maximum Drawdown
NEOG	2.08	(0.49)	(6.26)	3.92	(5.06)	12.07
OLK	0.00	0.00	0.00	0.00	0.00	0.00
ACRS	2.85	(1.25)	(2.66)	4.84	(7.95)	18.01
SYNH	0.00	0.00	0.00	0.00	0.00	0.00
IQV	1.25	(0.04)	(0.15)	2.70	(2.81)	7.16
MEDP	1.43	(0.01)	(0.12)	2.24	(3.94)	10.53
ICLR	1.44	(0.17)	(0.43)	3.28	(2.74)	11.42
SHC	1.40	(0.04)	(0.14)	2.40	(2.88)	12.51
AKU	0.00	0.00	0.00	0.00	0.00	0.00
GTH	0.00	0.00	0.00	0.00	0.00	0.00

Qiagen NV Corporate Management

John Gilardi	VP of Corporate Communications and Investor Relations	Profile
Stephane Bancel	Independent Member of the Supervisory Board	Profile
Fernando Beils	Senior Area	Profile
JeanPascal Viola	Senior Development	Profile
Elaine Mardis	Independent Member of the Supervisory Board	Profile
Thomas Ebeling	Independent Member of the Supervisory Board	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC